Cargando…
Immune‐suppressive effects of interleukin‐6 on T‐cell‐mediated anti‐tumor immunity
Accompanied by the growing clinical applications of immunotherapy in the treatment of cancer patients, development of novel therapeutic approaches to reverse the immune‐suppressive environment in cancer patients is eagerly anticipated, because the success of cancer immunotherapy is currently limited...
Autores principales: | Tsukamoto, Hirotake, Fujieda, Koji, Senju, Satoru, Ikeda, Tokunori, Oshiumi, Hiroyuki, Nishimura, Yasuharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834784/ https://www.ncbi.nlm.nih.gov/pubmed/29090850 http://dx.doi.org/10.1111/cas.13433 |
Ejemplares similares
-
IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age
por: Tsukamoto, Hirotake, et al.
Publicado: (2015) -
Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells
por: Ikeda, Tokunori, et al.
Publicado: (2014) -
Cancer therapy with major histocompatibility complex‐deficient and interferon β‐producing myeloid cells derived from allogeneic embryonic stem cells
por: Umemoto, Satoshi, et al.
Publicado: (2019) -
Aging-Associated Extracellular Vesicles Contain Immune Regulatory microRNAs Alleviating Hyperinflammatory State and Immune Dysfunction in the Elderly
por: Tsukamoto, Hirotake, et al.
Publicado: (2020) -
Extracellular Vesicles Deliver Host and Virus RNA and Regulate Innate Immune Response
por: Kouwaki, Takahisa, et al.
Publicado: (2017)